Item 16. FORM 10-K SUMMARY
34K characters. Original on sec.gov · Markdown
Item 16. FORM 10-K SUMMARY
Not applicable.
DANAHER CORPORATION
INDEX TO FINANCIAL STATEMENTS, SUPPLEMENTARY DATA AND FINANCIAL STATEMENT SCHEDULE
| Page Number in Form 10-K | |||||
| Schedule: | |||||
| Valuation and Qualifying Accounts | 107 |
EXHIBIT INDEX
| 31.2 | Certification of Chief Financial Officer Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||||||||||
| 32.1 | Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||||||||||
| 32.2 | Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||||||||||
| 97.1 | Danaher Corporation Clawback Policy | Incorporated by reference from Exhibit 97.1 to Danaher Corporation’s Annual Report on Form 10-K for the year ended December 31, 2023 | ||||||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. (4) | |||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document (4) | |||||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (4) | |||||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (4) | |||||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (4) | |||||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (4) | |||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||||||||
Danaher is a party to additional long-term debt instruments under which, in each case, the total amount of debt authorized does not exceed 10% of the total assets of Danaher and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Danaher agrees to furnish a copy of such instruments to the Securities and Exchange Commission upon request.
| * | Indicates management contract or compensatory plan, contract or arrangement. | |||||||
| (1) | In accordance with Instruction 2 to Item 601(a)(4) of Regulation S-K, FJ900, Inc. (a subsidiary of Danaher) has entered into a management agreement with Stonehavens Global LLC that is substantially identical in all material respects to the form of agreement referenced as Exhibit 10.25, except as to the referenced aircraft and the name of the counterparty. | |||||||
| (2) | In accordance with Instruction 2 to Item 601(a)(4) of Regulation S-K, Danaher Corporation or a subsidiary thereof has entered into additional interchange agreements with each of Joust Capital II, LLC and Joust Capital III, LLC that are substantially identical in all material respects to the form of agreement attached as Exhibit 10.26, except as to the referenced aircraft and, in certain cases, the name of the counterparty. | |||||||
| (3) | In accordance with Instruction 2 to Item 601(a)(4) of Regulation S-K, Danaher Corporation has entered into an aircraft time sharing agreement with Matthew R. McGrew that is substantially identical in all material respects to the form of agreement referenced as Exhibit 10.27. | |||||||
| (4) | Attached as Exhibit 101 to this report are the following documents formatted in Inline XBRL (Inline Extensible Business Reporting Language): (i) Consolidated Balance Sheets as of December 31, 2024 and 2023, (ii) Consolidated Statements of Earnings for the years ended December 31, 2024, 2023 and 2022, (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2024, 2023 and 2022, (iv) Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2024, 2023 and 2022, (v) Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022 and (vi) Notes to Consolidated Financial Statements. |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DANAHER CORPORATION | ||||||||||||||
| Date: | February 20, 2025 | By: | /s/ RAINER M. BLAIR | |||||||||||
| Rainer M. Blair | ||||||||||||||
| President and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this annual report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:
| Name, Title and Signature | Date | ||||||||||
| /s/ STEVEN M. RALES | February 20, 2025 | ||||||||||
| Steven M. Rales | |||||||||||
| Chairman of the Board | |||||||||||
| /s/ MITCHELL P. RALES | February 20, 2025 | ||||||||||
| Mitchell P. Rales | |||||||||||
| Chairman of the Executive Committee | |||||||||||
| /s/ RAINER M. BLAIR | February 20, 2025 | ||||||||||
| Rainer M. Blair | |||||||||||
| President, Chief Executive Officer and Director | |||||||||||
| /s/ FEROZ DEWAN | February 20, 2025 | ||||||||||
| Feroz Dewan | |||||||||||
| Director | |||||||||||
| /s/ LINDA FILLER | February 20, 2025 | ||||||||||
| Linda Filler | |||||||||||
| Director | |||||||||||
| /s/ CHARLES W. LAMANNA | February 20, 2025 | ||||||||||
| Charles W. Lamanna | |||||||||||
| Director | |||||||||||
| /s/ TERI LIST | February 20, 2025 | ||||||||||
| Teri List | |||||||||||
| Director | |||||||||||
| /s/ JESSICA L. MEGA, M.D., MPH | February 20, 2025 | ||||||||||
| Jessica L. Mega, M.D, MPH | |||||||||||
| Director | |||||||||||
| /s/ A. SHANE SANDERS | February 20, 2025 | ||||||||||
| A. Shane Sanders | |||||||||||
| Director | |||||||||||
| /s/ JOHN T. SCHWIETERS | February 20, 2025 | ||||||||||
| John T. Schwieters | |||||||||||
| Director | |||||||||||
| /s/ ALAN G. SPOON | February 20, 2025 | ||||||||||
| Alan G. Spoon | |||||||||||
| Director | |||||||||||
| /s/ RAYMOND C. STEVENS, Ph.D. | February 20, 2025 | ||||||||||
| Raymond C. Stevens, Ph.D. | |||||||||||
| Director | |||||||||||
| /s/ ELIAS A. ZERHOUNI, M.D. | February 20, 2025 | ||||||||||
| Elias A. Zerhouni, M.D. | |||||||||||
| Director | |||||||||||
| /s/ MATTHEW R. MCGREW | February 20, 2025 | ||||||||||
| Matthew R. McGrew | |||||||||||
| Executive Vice President and Chief Financial Officer | |||||||||||
| /s/ CHRISTOPHER M. BOUDA | February 20, 2025 | ||||||||||
| Christopher M. Bouda | |||||||||||
| Vice President and Chief Accounting Officer |
DANAHER CORPORATION AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
($ in millions)
| Classification | Balance at Beginning of Period (a) | Charged to Costs & Expenses | Impact of Currency | Charged to Other Accounts (b) | Write-Offs, Write-Downs & Deductions | Balance at End of Period (a) | |||||||||||||||||||||||||||||
| Year ended December 31, 2024: | |||||||||||||||||||||||||||||||||||
| Allowances deducted from asset account | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 121 | 37 | (3) | — | (42) | $ | 113 | |||||||||||||||||||||||||||
| Year ended December 31, 2023: | |||||||||||||||||||||||||||||||||||
| Allowances deducted from asset account | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 92 | 43 | — | 15 | (29) | $ | 121 | |||||||||||||||||||||||||||
| Year ended December 31, 2022: | |||||||||||||||||||||||||||||||||||
| Allowances deducted from asset account | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 90 | 20 | (4) | — | (14) | $ | 92 |
(a) Amounts include allowance for doubtful accounts classified as current and noncurrent.
(b) Amounts related to businesses acquired.
Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES